Background Alcohol use disorder and treatment-resistant depression (TRD) often co-occur, presenting a major clinical challenge with limited effective treatments. However, ketamine produces rapid ...
Researchers Gyanendra Singh and Josep Fontcuberta, from the Institute of Materials Science of Barcelona, have experimentally confirmed a theory they proposed in 2021 that explains the mechanism by ...
The FDA has published its first-ever guidance document on clinical trials with psychedelic drugs, an emerging treatment category for psychiatric and substance use disorders. The new document focuses ...
Scientists are exploring a new way to harness the medical promise of psychedelic compounds without the mind-bending side effects. Researchers created modified versions of psilocin — the active form of ...
Post-traumatic stress disorder (PTSD) is not only characterized by strongly encoded traumatic memories, but also by disrupted coordination across brain networks. New research shows that treatment with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results